Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × 1-phenyl-3,3-dimethyltriazene × 1 year × Clear all

Sponsor

Conditions

Pleural Diseases 2 Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Non-Muscle Invasive Bladder Neoplasms 1 Mesothelioma, Malignant 1 Keratosis, Actinic 1 Glioma 1 Glioblastoma 1 Epitheliod Malignant Pleural Mesothelioma 1 Carcinoma, Transitional Cell 1 Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡